AC Camargo Cancer Center

São Paulo, São Paulo 105401

6 studies enrolling now · 9 studies all time

What they study most

Advanced Breast Cancer, Breast Cancer, Breast Cancer Recurrent, Carcinoma, Non-Small-Cell Lung, Cervical Cancer, Estrogen Receptor Positive Tumor, Lymphoma, Mantle-Cell, Metastatic Castration-resistant Prostate Cancer, Metastatic Non-small Cell Lung Cancer With MTAP Deletion, Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Relapsed or Refractory Multiple Myeloma (RRMM)

Studies at this site

• A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer — Recruiting now
• A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2) — Recruiting now
• A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer — Recruiting now
• A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4) — Recruiting now
• A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion — Recruiting now
• Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) — Recruiting now
• Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) — Running, not enrolling
• A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer — Running, not enrolling
• Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression — Completed